SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures
PLOS One · 2025
DOI: 10.1371/journal.pone.0331212 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Christopher S Semancik und 20 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology and Population Studies Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Marylan…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Viral, COVID-19, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Science, Innovation, Technology and Telecomunications Ministry of Costa Rica.
Abstract (Originalsprache)
Previous SARS-CoV-2 research indicates that antibody levels and corresponding neutralization potential increase with additional exposures (comprising vaccination or infection), and that hybrid immunity resulting from combined vaccination and natural infection is more robust than either alone. However, it is unclear whether or how antibody levels increase or eventually plateau with repeated exposures and how SARS-CoV-2 exposure differs by sex or other demographic factors. Research regarding the association of antibody production with neutralization potential is also limited. We conducted this analysis within the RESPIRA population-based cohort in Costa Rica to investigate relationships between antibody levels and neutralization potential at increasing exposure levels. We examined immunological profiles from systematically defined single-exposure groups (one vaccine dose or one natural infection), double-exposure groups (two vaccine doses or one vaccine dose following a natural infection), and a triple-exposure group (two vaccine doses following a natural infection). We used a S1-RBD-based serological assay for antibody level detection and a pseudovirion assay for neutralization potential quantification. Using linear regression, we compared antibody levels and pseudoneutralization geometric mean titers between exposure groups. For single exposure groups, one vaccine dose was inferior to natural infection, but a second vaccine dose was superior to natural infection. For double exposure groups, those who were vaccinated once after infection developed higher levels of antibodies and higher neutralization potential compared with those who had only two vaccine doses. We note that peak antibody levels following an exposure may plateau after two exposures while neutralization potential continues to increase with a third exposure dose. Response patterns were comparable in males and females and in sensitivity analyses stratified by age, vaccine type, and pandemic wave. These results provide evidence that SARS-CoV-2 vaccination after COVID infection provides immunological benefit and suggest neutralization potential continues to increase after a second vaccine dose despite plateauing of antibody levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Epidemiology and Population Studies Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
- Agencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA (ACIB-FUNIN), San José, Costa Rica.
- Infections and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
- Caja Costarricense del Seguro Social, San José, Costa Rica.
- Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America.
- Ministerio de Salud, San José, Costa Rica.
ORCID-Profile: Christopher S Semancik, Rebeca Ocampo, Allan Hildesheim
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Cancer Institute
- Science, Innovation, Technology and Telecomunications Ministry of Costa Rica
- Costa Rican Biomedical Research Agency-Fundacion INCIENSA
Zitieren
APA
Semancik, C. S., Fantin, R., Butt, J., Abdelnour, A., Loria, V., Porras, C., Aparicio, A., Jackson, S. S., Wong-McClure, R., Ocampo, R., Morera, M., Zúñiga, M., Calderón, A., Cortés, B., Castro, R., Binder, M., Waterboer, T., Prevots, D. R., Herrero, R., …, & RESPIRA Study Group (2025). SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures. PLOS One. https://doi.org/10.1371/journal.pone.0331212
Vancouver
Semancik CS, Fantin R, Butt J, Abdelnour A, Loria V, Porras C, et al. SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures. PLOS One. 2025. doi:10.1371/journal.pone.0331212
BibTeX
@article{Semancik2025,
author = {Semancik, Christopher S and Fantin, Romain and Butt, Julia and Abdelnour, Arturo and Loria, Viviana and Porras, Carolina and Aparicio, Amada and Jackson, Sarah S and Wong-McClure, Roy and Ocampo, Rebeca and Morera, Melvin and Zúñiga, Michael and Calderón, Alejandro and Cortés, Bernal and Castro, Roberto and Binder, Marco and Waterboer, Tim and Prevots, D Rebecca and Herrero, Rolando and Hildesheim, Allan and RESPIRA Study Group, RESPIRA Study Group},
title = {SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331212}
}
EUVIMED